Castuner

Biotalk

Biotalk

Welcome to Biotalk, Locust Walk’s podcast for biotech deal makers and innovators.

Сайт подкаста

Слушайте в своём приложении

Эпизоды

28 эпизодов

  1. Biotalk Episode 39: Asia’s 2026 Q3 Report: Global Trends in Biopharma Transactions 11:52
  2. Biotalk Episode 38: 2026 Q3 Report: Global Trends in Biopharma Transactions 12:13
  3. Biotalk Episode 37: Asia’s 2026 Q2 Report: Global Trends in Biopharma Transactions 9:15
  4. Biotalk Episode 36: 2026 Q2 Report: Global Trends in Biopharma Transactions 12:10
  5. Biotalk Episode 35: Asia’s 2026 Q1 Report: Global Trends in Biopharma Transactions
  6. Biotalk Episode 34: 2026 Q1 Report: Global Trends in Biopharma Transactions 5:12
  7. Biotalk Episode 33: Asia’s 2025 Year-In-Review Report: Global Trends in Biopharma Transactions 6:08
  8. Biotalk Episode 32: 2025 Year-In-Review Report: Global Trends in Biopharma Transactions 11:24
  9. Episode 31: Asia’s 2025 Q3 Report: Global Trends in Biopharma Transactions 4:44
  10. Biotalk Episode 30: 2025 Q3 Report: Global Trends in Biopharma Transactions 13:18
  11. Episode 29: Asia’s 2025 Q2 Report: Global Trends in Biopharma Transactions 7:34
  12. Biotalk Episode 28: 2025 Q2 Report: Global Trends in Biopharma Transactions 17:28
  13. Episode 27: Inside the Biopharma Market: 2025 Outlook & Emerging Trends 7:47
  14. Episode 26: Asia’s 2025 Q1 Report: Global Trends in Biopharma Transactions 10:38
  15. Biotalk Episode 25: 2025 Q1 Report: Global Trends in Biopharma Transactions 13:17
  16. Biotalk Episode 24: Asia's 2024 Year-In-Review 12:29
  17. Biotalk Episode 23: 2024 Year-In-Review Report: Global Trends in Biopharma Transactions 13:46
  18. Biotalk Episode 22: A Conversation with Sudhir Agrawal of ARNAY Sciences 29:41
  19. Biotalk Episode 21: Analyzing the 2024 U.S. Election's Impact on Biotech 34:13
  20. Biotalk Episode 20: A Conversation with David Harel of CytoReason 34:01
  21. Biotalk Episode 19: 2024 Q3 Report: Global Trends in Biopharma Transactions 14:01
  22. Biotalk Episode 18: A Conversation with Lindsay Rosenwald of Fortress Biotech 26:21
  23. Biotalk Episode 16: A Conversation with Stephen Sands of Lazard 33:54
  24. Biotalk Episode 15: 2024 Q1 Report: Global Trends in Biopharma Transactions 11:03
  25. Biotalk Episode 13: 2023 Year-In-Review Report: Global Trends in Biopharma Transactions​ 11:09
  26. Biotalk Episode 12: A Conversation with Soufiane Aboulhouda of Nucleate 32:27
  27. Biotalk Episode 11: A Conversation with Shehnaaz Suliman of ReCode Therapeutics 1:00:20
  28. Biotalk Episode 10: A Conversation with Errik Anderson of Alloy Therapeutics 54:18